https://childrenshealthdefense.org/defender/singulair-montelukast-asthma-mental-health-fda/?utm_source=luminate&utm_medium=email&utm_campaign=defender&utm_id=20241126
https://childrenshealthdefense.org/defender/singulair-montelukast-asthma-mental-health-fda/?utm_source=luminate&utm_medium=email&utm_campaign=defender&utm_id=20241126
CHILDRENSHEALTHDEFENSE.ORG
Popular Asthma Drug May Cause Serious Mental Health Issues in Children and Adults, FDA Data Reveals
Singulair, a widely-prescribed asthma drug, may cause serious mental health issues, according to data revealed last week by the U.S. Food and Drug Administration (FDA). The FDA said it has no plans to update the drug’s label based on the new data.
0 Comentários 0 Compartilhamentos 466 Visualizações
Patrocinado